BIOSCIENCE

Bioscience

With the largest network of plasma donation centers in the world, the Bioscience Division is a leading producer of plasma-derived medicines for the treatment of rare, chronic, and sometimes life-threatening conditions.

To help ensure a reliable, consistent source of plasma medicines worldwide, we have an all-inclusive process that begins with plasma collection and continues through fractionation, purification, and production.
 

Plasma proteins

  • Immunoglobulins, particularly intravenous immunoglobin (IVIG) in immunology. Used mainly to treat primary immunodeficiencies and chronic inflammatory demyelinating polyneuropathy (CIDP), a rare neurological condition.
  • Albumin to restore circulating blood volume and protein loss in such physiopathological conditions as liver cirrhosis, trauma, cardio-circulatory insufficiency, or severe burns. Research currently underway to assess its potential to treat Alzheimer's.
  • Alpha-1-antitrypsin to treat alpha-1-antitrypsin deficiency, a rare genetic disease that can lead to severe lung diseases such as emphysema.
  • Factor VIII and other clotting factors for hematology used primarily to treat hemophilia and other conditions that may result in bleeding episodes, including internal bleeding with subsequent tissue and organ damage.
  • Antithrombin to treat hereditary antithrombin deficiency, a rare thrombophilia that can lead to thrombotic conditions.
  • Other specialty hyperimmune immunoglobulins to treat potentially fatal infections such as rabies, tetanus, hepatitis B, and Rh incompatibility.

Plasma quality and product safety

Plasma is the clear, liquid portion of the blood. About 90% is composed of water, while the remaining 10% contains hundreds of essential proteins. Without enough of one of these proteins, a person could have a life-threatening condition.

Donor health and patient safety are our top priorities. We ensure that all plasma donor centers are held to the highest quality and safety standards established by US and European health authorities.

Plasma collection is performed in highly controlled environments by professionally licensed and trained staff. This allows us to maintain very high standards of quality and safety for the medications we produce.

Ensuring the highest levels of quality and safety when producing plasma derivatives and making them available to healthcare professionals and their patients demands a lengthy, complex process which starts with the donation of plasma and continues until after the product has been administered to the patient. Thanks to PediGri® traceability system, healthcare professionals have immediate, easy and agile visibility of product batches. Visit https://pedigri.grifols.com for more information.

 

My dad has a genetic form of COPD (chronic obstructive pulmonary disease). Donating plasma helps make the same medications that he uses for his condition. For me, it is personal."

Jacob Del Rio, United States – plasma donor

 

I donate plasma because I know it helps people who are in need".

Brenda, United States – plasma donor